Rinkey Investments’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-25,310
| Closed | -$44.5K | – | 91 |
|
|
2024
Q3 | $44.5K | Hold |
25,310
| – | – | 0.01% | 79 |
|
|
2024
Q2 | $34.7K | Buy |
+25,310
| New | +$34.7K | 0.01% | 69 |
|
|
2024
Q1 | – | Sell |
-25,310
| Closed | -$62.3K | – | 72 |
|
|
2023
Q4 | $62.3K | Buy |
+25,310
| New | +$62.3K | 0.02% | 58 |
|
|
2023
Q3 | – | Sell |
-25,310
| Closed | -$75.9K | – | 49 |
|
|
2023
Q2 | $75.9K | Buy |
25,310
+100
| +0.4% | +$300 | 0.03% | 57 |
|
|
2023
Q1 | $67.6K | Hold |
25,210
| – | – | 0.04% | 53 |
|
|
2022
Q4 | $208K | Hold |
25,210
| – | – | 0.12% | 47 |
|
|
2022
Q3 | $226K | Buy |
25,210
+1,800
| +8% | +$16.1K | 0.17% | 32 |
|
|
2022
Q2 | $76K | Buy |
+23,410
| New | +$76K | 0.07% | 41 |
|
|
2022
Q1 | – | Sell |
-10
| Closed | – | – | 61 |
|
|
2021
Q4 | $0 | Buy |
+10
| New | – | ﹤0.01% | 256 |
|